CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS)

This study is currently recruiting participants.

Verified September 2012 by Central European Society for Anticancer Drug Research

Study NCT01206036 Information provided by Central European Society for Anticancer Drug Research

First Received on August 17, 2010. Last Updated on September 7, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Prostatic Neoplasms

Additional conditions recognized in this trial

Neoplasms

More general conditions related to this trial

Interventions listed in this trial

Docetaxel
Temsirolimus

Additional drug interventions recognized in this trial

Everolimus
Sirolimus

More general drug interventions related to this trial

Sponsors listed in this trial